Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Louis Portugal"'
Autor:
Peter S. Hammerman, Kevin P. White, Everett E. Vokes, Ezra E.W. Cohen, Mark W. Lingen, Kerstin Stenson, Elizabeth Blair, Louis Portugal, Alexander Langerman, Ralph R. Weichselbaum, Rebecca DeBoer, Johannes Brägelmann, Gad Getz, Michael S. Lawrence, Juok Cho, Petar Stojanov, Trevor J. Pugh, Christopher Brown, Thomas Stricker, Chandra S. Pedamallu, Arun Khattri, Michaela K. Keck, Zhixiang Zuo, Tanguy Y. Seiwert
Purpose: The genetic differences between human papilloma virus (HPV)–positive and –negative head and neck squamous cell carcinomas (HNSCC) remain largely unknown. To identify differential biology and novel therapeutic targets for both entities, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::887e88f5dff6ee320e843dfb112bf9ca
https://doi.org/10.1158/1078-0432.c.6522954
https://doi.org/10.1158/1078-0432.c.6522954
Autor:
Emily Papazian, DaraR. Adams, Matthew Du, Esther Wang, Nadieska Caballero, Paramita Das, Peleg Horowitz, Jay Pinto, Louis Portugal, Bakhtiar Yamini, Christopher R. Roxbury
Publikováno v:
International forum of allergyrhinologyREFERENCES.
Autor:
Ari J, Rosenberg, Nishant, Agrawal, Alexander T, Pearson, Zhen, Gooi, Elizabeth, Blair, Louis, Portugal, John F, Cursio, Aditya, Juloori, Jeffrey, Chin, Kathryn, Rouse, Victoria M, Villaflor, Tanguy Y, Seiwert, Evgeny, Izumchenko, Mark W, Lingen, Daniel J, Haraf, Everett E, Vokes
Publikováno v:
British journal of cancer. 127(8)
Recurrent head and neck squamous cell carcinoma (HNSCC) is associated with poor overall survival (OS). Prior studies suggested incorporation of nab-paclitaxel (A) may improve outcomes in recurrent HNSCC.This Phase I study evaluated induction with car
Autor:
Jessica, Yesensky, Nishant, Agrawal, Semirra, Bayan, Elizabeth, Blair, Louis, Portugal, Jason, Chan, David, Goldenberg, Zhen, Gooi
Publikováno v:
Headneck. 39(9)
This article is a continuation of the "Do You Know Your Guidelines" series, an initiative of the American Head and Neck Society's Education Committee to increase awareness of current best practices pertaining to head and neck cancer. The National Com
Autor:
Daniel T, Ginat, Louis, Portugal
Publikováno v:
Ear, nose,throat journal. 95(7)
Autor:
Zhen, Gooi, Jeremy, Richmon, Nishant, Agrawal, Elizabeth, Blair, Louis, Portugal, Everett, Vokes, Tanguy, Seiwert, Jonas, de Souza, Vassiliki, Saloura, Daniel, Haraf, David, Goldenberg, Jason, Chan
Publikováno v:
Headneck. 39(2)
This article is a continuation of the "Do You Know Your Guidelines" series, an initiative of the American Head and Neck Society's Education Committee to increase awareness of current best practices pertaining to head and neck cancer. The National Com
Autor:
Kevin S, Choe, Daniel J, Haraf, Abhishek, Solanki, Ezra E W, Cohen, Tanguy Y, Seiwert, Kerstin M, Stenson, Elizabeth A, Blair, Louis, Portugal, Victoria M, Villaflor, Mary Ellyn, Witt, Everett E, Vokes, Joseph K, Salama
Publikováno v:
Cancer. 117(20)
It has been shown that concomitant chemotherapy (C) with reirradiation (ReRT) is feasible and effective for select patients with recurrent or second primary head and neck cancer (HNC). To examine potential prognostic factors associated with survival,
Autor:
Daniel J, Haraf, Fred R, Rosen, Kerstin, Stenson, Athanassios, Argiris, Bharat B, Mittal, Mary Ellyn, Witt, Bruce E, Brockstein, Marcy A, List, Louis, Portugal, Harold, Pelzer, Ralph R, Weichselbaum, Everett E, Vokes
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(16 Pt 1)
Induction chemotherapy with carboplatin and paclitaxel followed by concomitant TFHX (paclitaxel, infusional 5-fluorouracil, hydroxyurea, and twice-daily radiation therapy administered every other week) has resulted in 70% 3-year survival in stage IV
Autor:
Fred R, Rosen, Daniel J, Haraf, Merrill S, Kies, Kerstin, Stenson, Louis, Portugal, Marcy A, List, Bruce E, Brockstein, Bharat B, Mittal, Alfred W, Rademaker, Mary Ellyn, Witt, Harold, Pelzer, Ralph R, Weichselbaum, Everett E, Vokes
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(5)
To expand on our experience with the combination of paclitaxel, fluorouracil, hydroxyurea, and twice daily irradiation (T-FHX) and to assess the impact of weekly administration of erythropoietin (r-HuEpo) on transfusion requirements, we conducted a P
Publikováno v:
Otolaryngology–Head and Neck Surgery. 113